Melovem

Pays: Union européenne

Langue: anglais

Source: EMA (European Medicines Agency)

Achète-le

Ingrédients actifs:

meloxicam

Disponible depuis:

Dopharma Research B.V.

Code ATC:

QM01AC06

DCI (Dénomination commune internationale):

meloxicam

Groupe thérapeutique:

Pigs; Calves

Domaine thérapeutique:

Oxicams

indications thérapeutiques:

CattleFor use in acute respiratory infection with appropriate antibiotic therapy to reduce clinical signs in cattle. For use in diarrhoea in combination with oral rehydration therapy to reduce clinical signs in calves of over one week of age and young, non-lactating cattle. For adjunctive therapy in the treatment of acute mastitis, in combination with antibiotic therapy.PigsFor use in noninfectious locomotor disorders to reduce the symptoms of lameness and inflammation. For the relief of postoperative pain associated with minor soft-tissue surgery such as castration. For adjunctive therapy in the treatment of puerperal septicaemia and toxaemia (mastitis-metritis-agalactia syndrome) with appropriate antibiotic therapy.HorsesFor use in the alleviation of inflammation and relief of pain in both acute and chronic musculoskeletal disorders. For the relief of pain associated with equine colic.

Descriptif du produit:

Revision: 5

Statut de autorisation:

Authorised

Date de l'autorisation:

2009-07-07

Notice patient

                                35
B. PACKAGE LEAFLET
36
PACKAGE LEAFLET FOR:
Melovem 5 mg/ml solution for injection for cattle and pigs
1.
NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER AND OF
THE MANUFACTURING AUTHORISATION HOLDER RESPONSIBLE FOR BATCH
RELEASE, IF DIFFERENT
Marketing authorisation holder:
Dopharma Research B.V.
Zalmweg 24
4941 VX Raamsdonksveer The Netherlands
Manufacturer responsible for batch release:
Dopharma B.V.
Zalmweg 24
4941 VX Raamsdonksveer The Netherlands
2.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Melovem 5 mg/ml solution for injection for cattle and pigs
Meloxicam
3.
STATEMENT OF THE ACTIVE SUBSTANCE(S) AND OTHER INGREDIENT(S)
Each ml contains:
ACTIVE SUBSTANCE:
Meloxicam 5 mg
EXCIPIENT(S):
Benzyl alcohol 50 mg
A clear, greenish yellow solution.
4.
INDICATION(S)
CATTLE:
For use in acute respiratory infection with appropriate antibiotic
therapy to reduce clinical signs in
cattle.
For use in diarrhoea in combination with oral re-hydration therapy to
reduce clinical signs in calves of
over one week of age and young, non-lactating cattle.
For the relief of post-operative pain following dehorning in calves.
PIGS:
For use in non-infectious locomotor disorders to reduce the symptoms
of lameness and inflammation.
For the relief of post operative pain associated with minor soft
tissue surgery such as castration.
5.
CONTRAINDICATIONS
Do not use in animals suffering from impaired hepatic, cardiac or
renal function and haemorrhagic
disorders, or where there is evidence of ulcerogenic gastrointestinal
lesions.
37
Do not use in case of hypersensitivity to the active substance or to
any of the excipients.
For the treatment of diarrhoea in cattle, do not use in animals of
less than one week of age.
Do not use in pigs less than 2 days old.
6.
ADVERSE REACTIONS
Transient swelling at the injection site was commonly reported in
clinical studies following
subcutaneous administration in cattle. Injection site swelling may be
painful.
Transient swelling at the injection site was observed in clinical
studies following intramuscu
                                
                                Lire le document complet
                                
                            

Résumé des caractéristiques du produit

                                1
ANNEX I
SUMMARY OF PRODUCT CHARACTERISTICS
2
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Melovem 5 mg/ml solution for injection for cattle and pigs
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each ml contains:
ACTIVE SUBSTANCE:
Meloxicam 5 mg
EXCIPIENT(S):
Benzyl alcohol 50 mg
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Solution for injection.
Clear, greenish yellow solution.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Cattle (calves and young cattle) and pigs.
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Cattle:
For use in acute respiratory infection with appropriate antibiotic
therapy to reduce clinical signs in
cattle.
For use in diarrhoea in combination with oral re-hydration therapy to
reduce clinical signs in calves of
over one week of age and young, non-lactating cattle.
For the relief of post-operative pain following dehorning in calves.
Pigs:
For use in non-infectious locomotor disorders to reduce the symptoms
of lameness and inflammation.
For the relief of post operative pain associated with minor soft
tissue surgery such as castration.
4.3
CONTRAINDICATIONS
Do not use in animals suffering from impaired hepatic, cardiac or
renal function and haemorrhagic
disorders, or where there is evidence of ulcerogenic gastrointestinal
lesions.
Do not use in case of hypersensitivity to the active substance or to
any of the excipients.
For the treatment of diarrhoea in cattle, do not use in animals of
less than one week of age.
Do not use in pigs less than 2 days old.
3
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
Treatment of calves with Melovem 20 minutes before dehorning reduces
post-operative pain.
Melovem alone will not provide adequate pain relief during the
dehorning procedure. To obtain
adequate pain relief during surgery co-medication with an appropriate
analgesic is needed.
Treatment of piglets with Melovem before castration reduces post
operative pain. To obtain pain relief
during surgery co-medication with an appropriate anaesthetic/sedative
is needed.
To obtain the
                                
                                Lire le document complet
                                
                            

Documents dans d'autres langues

Notice patient Notice patient bulgare 19-06-2014
Rapport public d'évaluation Rapport public d'évaluation bulgare 10-10-2013
Notice patient Notice patient espagnol 19-06-2014
Rapport public d'évaluation Rapport public d'évaluation espagnol 10-10-2013
Notice patient Notice patient tchèque 19-06-2014
Rapport public d'évaluation Rapport public d'évaluation tchèque 10-10-2013
Notice patient Notice patient danois 19-06-2014
Rapport public d'évaluation Rapport public d'évaluation danois 10-10-2013
Notice patient Notice patient allemand 19-06-2014
Rapport public d'évaluation Rapport public d'évaluation allemand 10-10-2013
Notice patient Notice patient estonien 19-06-2014
Rapport public d'évaluation Rapport public d'évaluation estonien 10-10-2013
Notice patient Notice patient grec 19-06-2014
Notice patient Notice patient français 19-06-2014
Rapport public d'évaluation Rapport public d'évaluation français 10-10-2013
Notice patient Notice patient italien 19-06-2014
Rapport public d'évaluation Rapport public d'évaluation italien 10-10-2013
Notice patient Notice patient letton 19-06-2014
Rapport public d'évaluation Rapport public d'évaluation letton 10-10-2013
Notice patient Notice patient lituanien 19-06-2014
Rapport public d'évaluation Rapport public d'évaluation lituanien 10-10-2013
Notice patient Notice patient hongrois 19-06-2014
Rapport public d'évaluation Rapport public d'évaluation hongrois 10-10-2013
Notice patient Notice patient maltais 19-06-2014
Rapport public d'évaluation Rapport public d'évaluation maltais 10-10-2013
Notice patient Notice patient néerlandais 19-06-2014
Rapport public d'évaluation Rapport public d'évaluation néerlandais 10-10-2013
Notice patient Notice patient polonais 19-06-2014
Rapport public d'évaluation Rapport public d'évaluation polonais 10-10-2013
Notice patient Notice patient portugais 19-06-2014
Rapport public d'évaluation Rapport public d'évaluation portugais 10-10-2013
Notice patient Notice patient roumain 19-06-2014
Rapport public d'évaluation Rapport public d'évaluation roumain 10-10-2013
Notice patient Notice patient slovaque 19-06-2014
Rapport public d'évaluation Rapport public d'évaluation slovaque 10-10-2013
Notice patient Notice patient slovène 19-06-2014
Rapport public d'évaluation Rapport public d'évaluation slovène 10-10-2013
Notice patient Notice patient finnois 19-06-2014
Rapport public d'évaluation Rapport public d'évaluation finnois 10-10-2013
Notice patient Notice patient suédois 19-06-2014
Rapport public d'évaluation Rapport public d'évaluation suédois 10-10-2013
Notice patient Notice patient norvégien 19-06-2014
Notice patient Notice patient islandais 19-06-2014
Notice patient Notice patient croate 19-06-2014
Rapport public d'évaluation Rapport public d'évaluation croate 10-10-2013

Rechercher des alertes liées à ce produit

Afficher l'historique des documents